Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Nuclear Medicine-Radiopharmaceuticals Market Report 2016

  • QYR791098
  • 114 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Nuclear Medicine-Radiopharmaceuticals

Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals

This report studies sales (consumption) of Nuclear Medicine-Radiopharmaceuticals in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Cardinal Health, Inc (US)

GE Healthcare (UK)

Bracco Imaging S.p.A (Italy)

Nordion, Inc. (Canada)

Bayer HealthCare Medical Care (US)

Lantheus Medical Imaging Inc (US)

Advanced Medical Isotope Corporation (US)

Alliance Medical (UK)

Alseres Pharmaceuticals, Inc (US)

Avid Radiopharmaceuticals (US)

Actinium Pharmaceuticals Inc (US)

Ion Beam Applications S.A (Belgium)

Immunomedics, Inc. (US)

Jubilant Pharma (India)

Mallinckrodt Pharmaceuticals (Ireland)

Medi-Radiopharma Ltd (Hungary)

Peregrine Pharmaceuticals, Inc. (US)

Siemens Healthcare (US)

Positron Corporation (US)

Triad Isotopes, Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

Type III

Split by application, this report focuses on sales, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in each application, can be divided into

Diagnostic Applications: SPECT, PET.

Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

Application 3

Table of Contents

Europe Nuclear Medicine-Radiopharmaceuticals Market Report 2016

1 Nuclear Medicine-Radiopharmaceuticals Overview

1.1 Product Overview and Scope of Nuclear Medicine-Radiopharmaceuticals

1.2 Classification of Nuclear Medicine-Radiopharmaceuticals

1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

1.2.3 Type III

1.3 Application of Nuclear Medicine-Radiopharmaceuticals

1.3.1 Diagnostic Applications: SPECT, PET.

1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

1.3.3 Application 3

1.4 Nuclear Medicine-Radiopharmaceuticals Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Nuclear Medicine-Radiopharmaceuticals (2011-2021)

1.5.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)

1.5.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

2 Europe Nuclear Medicine-Radiopharmaceuticals by Manufacturers, Type and Application

2.1 Europe Nuclear Medicine-Radiopharmaceuticals Market Competition by Manufacturers

2.1.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Type

2.2.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)

2.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)

2.3 Europe Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Countries

2.3.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Countries (2011-2016)

2.4 Europe Nuclear Medicine-Radiopharmaceuticals (Volume) by Application

3 Germany Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

3.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

3.1.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

3.1.2 Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

3.1.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

3.2 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

3.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

3.4 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

4 France Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

4.1 France Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

4.1.1 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

4.1.2 France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

4.1.4 France Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

4.2 France Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

4.3 France Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

4.4 France Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

5 UK Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

5.1 UK Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

5.1.1 UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

5.1.2 UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

5.1.5 UK Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

5.2 UK Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

5.3 UK Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

5.4 UK Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

6 Russia Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

6.1 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

6.1.1 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

6.1.2 Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

6.1.6 Russia Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

6.2 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

6.3 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

6.4 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

7 Italy Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

7.1 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

7.1.1 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

7.1.2 Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

7.1.7 Italy Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

7.2 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

7.3 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

7.4 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

8 Spain Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

8.1 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

8.1.1 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

8.1.2 Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

8.1.8 Spain Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

8.2 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

8.3 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

8.4 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

9 Benelux Nuclear Medicine-Radiopharmaceuticals (Volume, Value and Sales Price)

9.1 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Value (2011-2016)

9.1.1 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

9.1.2 Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

9.2 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Manufacturers

9.3 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type

9.4 Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application

10 Europe Nuclear Medicine-Radiopharmaceuticals Manufacturers Analysis

10.1 Cardinal Health, Inc (US)

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 GE Healthcare (UK)

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Bracco Imaging S.p.A (Italy)

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Nordion, Inc. (Canada)

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Bayer HealthCare Medical Care (US)

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Lantheus Medical Imaging Inc (US)

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Advanced Medical Isotope Corporation (US)

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Alliance Medical (UK)

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Alseres Pharmaceuticals, Inc (US)

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Avid Radiopharmaceuticals (US)

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Actinium Pharmaceuticals Inc (US)

10.12 Ion Beam Applications S.A (Belgium)

10.13 Immunomedics, Inc. (US)

10.14 Jubilant Pharma (India)

10.15 Mallinckrodt Pharmaceuticals (Ireland)

10.16 Medi-Radiopharma Ltd (Hungary)

10.17 Peregrine Pharmaceuticals, Inc. (US)

10.18 Siemens Healthcare (US)

10.19 Positron Corporation (US)

10.20 Triad Isotopes, Inc. (US)

11 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Analysis

11.1 Nuclear Medicine-Radiopharmaceuticals Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Nuclear Medicine-Radiopharmaceuticals Market Forecast (2016-2021)

14.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.2 France Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.3 UK Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.4 Russia Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.5 Italy Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.6 Spain Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.7 Benelux Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2016-2021)

14.8 Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)

14.9 Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Nuclear Medicine-Radiopharmaceuticals

Table Classification of Nuclear Medicine-Radiopharmaceuticals

Figure Europe Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015

Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Picture

Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Picture

Table Application of Nuclear Medicine-Radiopharmaceuticals

Figure Europe Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application in 2015

Figure Diagnostic Applications: SPECT, PET. Examples

Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples

Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales of Key Manufacturers (2015 and 2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers

Figure 2016 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue by Manufacturers (2015 and 2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers

Table 2016 Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Type (2011-2016)

Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Type (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue Growth Rate by Type (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Countries (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Countries (2011-2016)

Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Countries (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Countries (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Countries (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application (2011-2016)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Share by Application (2011-2016)

Figure Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application (2011-2016)

Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table Germany Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table Germany Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table Germany Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table Germany Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table Germany Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table Germany Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure France Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table France Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table France Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table France Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table France Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table France Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table France Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure UK Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table UK Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table UK Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table UK Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table UK Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table UK Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table UK Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table Russia Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table Russia Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table Russia Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table Russia Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table Russia Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table Russia Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table Italy Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table Italy Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table Italy Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table Italy Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table Italy Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table Italy Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table Spain Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table Spain Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table Spain Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table Spain Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table Spain Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table Spain Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Figure Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2016)

Figure Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2016)

Figure Benelux Nuclear Medicine-Radiopharmaceuticals Sales Price Trend (2011-2016)

Table Benelux Nuclear Medicine-Radiopharmaceuticals Sales by Manufacturers (2015 and 2016)

Table Benelux Nuclear Medicine-Radiopharmaceuticals Market Share by Manufacturers (2015 and 2016)

Table Benelux Nuclear Medicine-Radiopharmaceuticals Sales by Type (2015 and 2016)

Table Benelux Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2015 and 2016)

Table Benelux Nuclear Medicine-Radiopharmaceuticals Sales by Application (2015 and 2016)

Table Benelux Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2015 and 2016)

Table Nuclear Medicine-Radiopharmaceuticals Basic Information List

Table Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table GE Healthcare (UK) Basic Information List

Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Bracco Imaging S.p.A (Italy) Basic Information List

Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Nordion, Inc. (Canada) Basic Information List

Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Bayer HealthCare Medical Care (US) Basic Information List

Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Lantheus Medical Imaging Inc (US) Basic Information List

Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Advanced Medical Isotope Corporation (US) Basic Information List

Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Alliance Medical (UK) Basic Information List

Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Alseres Pharmaceuticals, Inc (US) Basic Information List

Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Avid Radiopharmaceuticals (US) Basic Information List

Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Actinium Pharmaceuticals Inc (US) Basic Information List

Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Ion Beam Applications S.A (Belgium) Basic Information List

Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Immunomedics, Inc. (US) Basic Information List

Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Jubilant Pharma (India) Basic Information List

Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Mallinckrodt Pharmaceuticals (Ireland) Basic Information List

Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Medi-Radiopharma Ltd (Hungary) Basic Information List

Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Peregrine Pharmaceuticals, Inc. (US) Basic Information List

Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Siemens Healthcare (US) Basic Information List

Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Positron Corporation (US) Basic Information List

Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Triad Isotopes, Inc. (US) Basic Information List

Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals

Figure Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

Figure Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis

Table Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

Table Major Buyers of Nuclear Medicine-Radiopharmaceuticals

Table Distributors/Traders List

Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370